Overview: Urine WBC TestIntroduction: The Urine WBC Test detects white blood cells in urine to diagnose infections or inflammation, helping guide treatment for pain or fever. Affecting 1 in 2 women annually, WBC presence poses diagnostic challenges due to overlap with other conditions. Following 2023 Clinical and Laboratory Standards Institute (CLSI) guidelines, it uses microscopy for high accuracy, supporting general pathology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in urology.
Other Names: Urine White Cell Count Test, Inflammation Assay.
FDA Status: Laboratory-developed test (LDT), meeting pathology standards for diagnostic reliability.
Historical Milestone: Urine WBC testing began in the 1960s with research by Stamm, who linked it to infections. Microscopy advancements improved detection, surpassing earlier dipstick methods.
Purpose: Detects WBC count to diagnose infections or inflammation, guides antibiotic therapy, and evaluates patients with pain, aiming to resolve infection.
Test Parameters: WBC count
Pretest Condition: Fresh urine sample required. Collect urine. Report history of urinary issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document painful urination or fever. Include current medications or urinary history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., pyelonephritis), and sample collection risks.
Procedural Considerations: Uses microscopy to count WBCs, requiring labs with trained staff. Results available in 1 day. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Medications may alter counts, requiring correlation.
Clinical Significance: Elevated count suggests infection, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal count may require other tests.
Specialist Consultation: Consult a urologist for interpretation.
Additional Supporting Tests: Urinalysis, culture, or imaging to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False positives possible with inflammation.
References: CLSI Guidelines, 2023; Journal of Infectious Diseases, Stamm WE, 2022.
